Загрузка...
Dupilumab in atopic dermatitis: rationale, latest evidence and place in therapy
Atopic dermatitis (AD) is one of the most common chronic inflammatory skin diseases. The prevalence of AD is increasing and is currently estimated at 10–20% in adults worldwide. In the majority of patients, AD can be adequately controlled with topical treatment or ultraviolet light therapy, but ther...
Сохранить в:
| Опубликовано в: : | Ther Adv Chronic Dis |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6116085/ https://ncbi.nlm.nih.gov/pubmed/30181845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040622318773686 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|